Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, Tehran University of Medical Sciences, Tehran, Iran.
Arch Iran Med. 2011 Jul;14(4):276-80.
Neovascularization is an important factor for predicting tumor behavior. Evidence suggests that endoglin (CD105) is a powerful marker of neovascularization and determination of microvessel density in several malignancies, and can be used as an agent to predict lymph node metastasis. However, it is controversial, particularly in head and neck squamous cell carcinoma. We studied CD105-MVD in tongue squamous cell carcinoma and evaluated its correlation with lymph node metastasis in relation to sex, age, and histopathologic grade.
This study analyzed a total of 40 cases of tongue squamous cell carcinoma by dividing patients into two groups, a) with metastatic lymph nodes (N+) and b) without metastatic lymph nodes (N-). By CD105 immunostaining, microvessel density was determined in three different areas (intratumoral, invasive front and adjacent normal tissue) of all cases. Statistically, we evaluated the relation between microvessel density and lymph node involvement, in addition to other clinicopathologic factors by using the Kolmogorov-Smirnov test, t-test, and other analyses.
CD105-MVD in the invasive front (P≤0.001) and intratumoral (P≤0.006) areas of the N+ group was significantly higher than in the N-group. In addition, there was a correlation between CD105-MVD and differentiation in the invasive front area (P≤ 0.013) No relation existed between CD105-MVD and other clinicopathologic features.
CD105-MVD, as a prognostic factor, may be helpful for determining the possibility of lymph node metastasis of primary SCC of the tongue.
血管新生是预测肿瘤行为的一个重要因素。有证据表明,内皮糖蛋白(CD105)是多种恶性肿瘤中血管新生和微血管密度的有力标志物,可作为预测淋巴结转移的标志物。然而,在头颈部鳞状细胞癌中,其作用存在争议。我们研究了舌鳞状细胞癌中的 CD105-MVD,并评估了其与淋巴结转移的相关性,同时还考虑了性别、年龄和组织病理学分级等因素。
本研究共分析了 40 例舌鳞状细胞癌患者,将患者分为两组:a)有转移淋巴结(N+)组和 b)无转移淋巴结(N-)组。通过 CD105 免疫组化染色,在所有病例的三个不同区域(肿瘤内、侵袭前沿和相邻正常组织)中确定微血管密度。通过使用 Kolmogorov-Smirnov 检验、t 检验和其他分析,统计评估了微血管密度与淋巴结受累以及其他临床病理因素之间的关系。
N+组的侵袭前沿(P≤0.001)和肿瘤内(P≤0.006)区域的 CD105-MVD 明显高于 N-组。此外,在侵袭前沿区域,CD105-MVD 与分化之间存在相关性(P≤0.013),但与其他临床病理特征之间无相关性。
作为一种预后因素,CD105-MVD 可能有助于确定原发性舌鳞状细胞癌发生淋巴结转移的可能性。